Patients with antiphospholipid syndrome can suffer recurrent thrombosis that is very difficult to manage. Recent research has demonstrated that high-intensity anticoagulation is not superior to standard therapy. Basic questions about the nature and treatment of this syndrome remain unanswered.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3949/ccjm.72.3.245 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!